Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pediatric Nephrology
Literature
1.
Edwards JCW, Cambridge G (2001) Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford) 40(2):205–211CrossRef
2.
Ganne V, Siddiqi N, Kamaplath B, Chang CC, Cohen EP, Bresnahan BA, Hariharan S (2003) Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder. Clin Transplant 17(5):417–422CrossRef
3.
Gorman C, Leandro M, Isenberg D (2003) B cell depletion in autoimmune disease. Arthritis Res Ther 5(Suppl 4):S17–S21CrossRef
4.
Hainsworth JD, Burris HA 3rd, Morrissey LH, Litchy S, Scullin DC Jr, Bearden JD 3rd, Richards P, Greco FA (2000) Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma. Blood 95(10):3052–3056CrossRef
5.
Kazkaz H, Isenberg D (2004) Anti B cell therapy (rituximab) in the treatment of autoimmune diseases. Curr Opin Pharmacol 4(4):398–402CrossRef
6.
Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA (2005) B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) 44(12):1542–1545CrossRef
7.
Marks SD, Patey S, Brogan PA, Hasson N, Pilkington C, Woo P, Tullus K (2005) B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus. Arthritis Rheum 52(10):3168–3174CrossRef
8.
Nozu K, Iijima K, Fujisawa M, Nakagawa A, Yoshikawa N, Matsuo M (2005) Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol 20(11):1660–1663CrossRef
9.
Pescovitz MD, Book BK, Sidner RA (2006) Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 354(18):1961–1963CrossRef
10.
Cochat P, Kassir A, Cohen S, Glastre C, Tourniaire B, Parchoux B, Martin X, David L (1993) Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol 7(1):50–54CrossRef
Metadata
Title
Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation?
Authors
Stephen D. Marks
Mary McGraw
Publication date
01-01-2007
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 1/2007
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0260-x

Other articles of this Issue 1/2007

Pediatric Nephrology 1/2007 Go to the issue

Brief Report

End-stage renal disease as the presenting manifestation of renal systemic lupus erythematosus

Review

Chronic allograft nephropathy in paediatric renal transplantation

Letter to the Editors

Pulmonary edema in a boy with biopsy-proven poststreptococcal glomerulonephritis without urinary abnormalities

Brief Report

Regression of left ventricular hypertrophy in children with antihypertensive therapy

Editorial

Changes in Pediatric Nephrology for 2007

Editorial Commentary

MPGN II – genetically determined by defective complement regulation?